Objective To investigate the Mirena IUD (ING-IUS) clinical efficacy in the treatment of adenomyosis. Methods 2010 January to 2013 September in our hospital on the basis of clinical symptoms, color Doppler ultrasoundor CT confirmed the diagnosis of adenomyosis of the data of 58 patients, patients in the menstruation 3~7d is placed in the ING-IUS, the patients were observed before and after treatment, 3, 6,12 months, menstruation, dysmenorrheascores of hemoglobin, endometrium thickness, uterine volume change. Resuls After ING-IUS placement, 3 menstrual cycle 6, 12 months, the amount of dysmenorrhea score, uterine volume, endometrial thickness was significantly lower than that before treatment, the difference was statistically signiifcant (P<0.05). Conclusion ING-IUS can effectively improve the muscle in patients with uterine gland volume menstruation, menstrual pain, endometrial thickness, uterine volume and other clinical symptoms, treatment effect of safe, reliable, worthy of clinical application.%目的：探讨曼月乐宫内节育器（ING-IUS）治疗子宫腺肌症的临床疗效。方法选择2010年1月～2013年9月来我院诊治依据临床症状、彩超或CT确诊为子宫腺肌病的58例患者的资料，患者于月经后3～7天内放置ING-IUS，观察患者治疗前、治疗后3、6、12个月血红蛋白、月经量、痛经评分、子宫内膜厚度、子宫体积变化。结果放置ING-IUS后3、6、12个月月经量、痛经评分、子宫体积、子宫内膜厚度显著低于治疗前，差异有统计学意义（P＜0.05）。结论 ING-IUS能有效改善子宫腺肌症患者月经量、月经疼痛、子宫内膜厚度、子宫体积等临床症状，疗效安全、可靠，值得临床应用推广。
展开▼
